142 related articles for article (PubMed ID: 19690460)
1. A homeostatic switch in PACS-2 links membrane traffic to TRAIL-induced apoptosis.
You H; Thomas G
Cell Cycle; 2009 Sep; 8(17):2679-80. PubMed ID: 19690460
[No Abstract] [Full Text] [Related]
2. Akt and 14-3-3 control a PACS-2 homeostatic switch that integrates membrane traffic with TRAIL-induced apoptosis.
Aslan JE; You H; Williamson DM; Endig J; Youker RT; Thomas L; Shu H; Du Y; Milewski RL; Brush MH; Possemato A; Sprott K; Fu H; Greis KD; Runckel DN; Vogel A; Thomas G
Mol Cell; 2009 May; 34(4):497-509. PubMed ID: 19481529
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein-induced lysosomal translocation of proapoptotic effectors is mediated by phosphofurin acidic cluster sorting protein-2 (PACS-2).
Werneburg NW; Bronk SF; Guicciardi ME; Thomas L; Dikeakos JD; Thomas G; Gores GJ
J Biol Chem; 2012 Jul; 287(29):24427-37. PubMed ID: 22645134
[TBL] [Abstract][Full Text] [Related]
4. Cellular inhibitor of apoptosis (cIAP)-mediated ubiquitination of phosphofurin acidic cluster sorting protein 2 (PACS-2) negatively regulates tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity.
Guicciardi ME; Werneburg NW; Bronk SF; Franke A; Yagita H; Thomas G; Gores GJ
PLoS One; 2014; 9(3):e92124. PubMed ID: 24633224
[TBL] [Abstract][Full Text] [Related]
5. Calcium/calmodulin-dependent protein kinase II (CaMKII) regulates tumour necrosis factor-related apoptosis inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells (FLS) by phosphorylation of Akt.
Fujikawa K; Kawakami A; Tanaka F; Iwamoto N; Tamai M; Eguchi K
Clin Exp Rheumatol; 2009; 27(6):952-7. PubMed ID: 20149311
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-specific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Panner A; Crane CA; Weng C; Feletti A; Fang S; Parsa AT; Pieper RO
Cancer Res; 2010 Jun; 70(12):5046-53. PubMed ID: 20484045
[TBL] [Abstract][Full Text] [Related]
7. Simultaneously targeting Bcl-2 and Akt pathways reverses resistance of nasopharyngeal carcinoma to TRAIL synergistically.
Li SS; Tang QL; Wang SH; Chen YH; Liu JJ; Yang XM
Tumori; 2011; 97(6):762-70. PubMed ID: 22322844
[TBL] [Abstract][Full Text] [Related]
8. Reovirus infection induces apoptosis of TRAIL-resistant gastric cancer cells by down-regulation of Akt activation.
Cho IR; Koh SS; Min HJ; Park EH; Srisuttee R; Jhun BH; Kang CD; Kim M; Johnston RN; Chung YH
Int J Oncol; 2010 Apr; 36(4):1023-30. PubMed ID: 20198349
[TBL] [Abstract][Full Text] [Related]
9. Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression.
Wang C; Qi R; Li N; Wang Z; An H; Zhang Q; Yu Y; Cao X
J Biol Chem; 2009 Jun; 284(24):16183-16190. PubMed ID: 19376776
[TBL] [Abstract][Full Text] [Related]
10. Ischemic Preconditioning Upregulates Decoy Receptors to Protect SH-SY5Y Cells from OGD Induced Cellular Damage by Inhibiting TRAIL Pathway and Agitating PI3K/Akt Pathway.
Jin W; Xu W; Zhang X; Ren CC
Mol Neurobiol; 2020 Sep; 57(9):3658-3670. PubMed ID: 32564286
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt/NF-κB signaling.
Rasheduzzaman M; Jeong JK; Park SY
Life Sci; 2018 Sep; 208():208-220. PubMed ID: 30031063
[TBL] [Abstract][Full Text] [Related]
13. TRAIL-R4 promotes tumor growth and resistance to apoptosis in cervical carcinoma HeLa cells through AKT.
Lalaoui N; Morlé A; Mérino D; Jacquemin G; Iessi E; Morizot A; Shirley S; Robert B; Solary E; Garrido C; Micheau O
PLoS One; 2011; 6(5):e19679. PubMed ID: 21625476
[TBL] [Abstract][Full Text] [Related]
14. The TRAIL to acne pathogenesis: let's focus on death pathways.
Melnik BC
Exp Dermatol; 2017 Mar; 26(3):270-272. PubMed ID: 27541445
[TBL] [Abstract][Full Text] [Related]
15. A novel PTEN-dependent link to ubiquitination controls FLIPS stability and TRAIL sensitivity in glioblastoma multiforme.
Panner A; Crane CA; Weng C; Feletti A; Parsa AT; Pieper RO
Cancer Res; 2009 Oct; 69(20):7911-6. PubMed ID: 19808964
[TBL] [Abstract][Full Text] [Related]
16. HSP27 phosphorylation modulates TRAIL-induced activation of Src-Akt/ERK signaling through interaction with β-arrestin2.
Qi S; Xin Y; Qi Z; Xu Y; Diao Y; Lan L; Luo L; Yin Z
Cell Signal; 2014 Mar; 26(3):594-602. PubMed ID: 24308965
[TBL] [Abstract][Full Text] [Related]
17. TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma.
Keuper M; Wernstedt Asterholm I; Scherer PE; Westhoff MA; Möller P; Debatin KM; Strauss G; Wabitsch M; Fischer-Posovszky P
Cell Death Dis; 2013 Jan; 4(1):e474. PubMed ID: 23348588
[TBL] [Abstract][Full Text] [Related]
18. Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis.
Ou YC; Li JR; Kuan YH; Raung SL; Wang CC; Hung YY; Pan PH; Lu HC; Chen CJ
Life Sci; 2014 Apr; 100(2):110-117. PubMed ID: 24530290
[TBL] [Abstract][Full Text] [Related]
19. Targeting TNF-related apoptosis-inducing ligand (TRAIL) receptor by natural products as a potential therapeutic approach for cancer therapy.
Dai X; Zhang J; Arfuso F; Chinnathambi A; Zayed ME; Alharbi SA; Kumar AP; Ahn KS; Sethi G
Exp Biol Med (Maywood); 2015 Jun; 240(6):760-73. PubMed ID: 25854879
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of malignant peripheral nerve sheath tumor cells to TRAIL is augmented by loss of NF1 through modulation of MYC/MAD and is potentiated by curcumin through induction of ROS.
Reuss DE; Mucha J; Hagenlocher C; Ehemann V; Kluwe L; Mautner V; von Deimling A
PLoS One; 2013; 8(2):e57152. PubMed ID: 23437333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
